相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Association of UGT2B7 and ABCB1 genotypes with morphine-induced adverse drug reactions in Japanese patients with cancer
Ken-ichi Fujita et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
Prediction of Deleterious Non-synonymous Single-Nucleotide Polymorphisms of Human Uridine Diphosphate Glucuronosyltransferase Genes
Yuan Ming Di et al.
AAPS JOURNAL (2009)
Single nucleotide polymorphism discovery and functional assessment of variation in the UDP-glucuronosyltransferase 2B7 gene
Federico Innocenti et al.
PHARMACOGENETICS AND GENOMICS (2008)
Association of ABCB1/MDR1 and OPRM1 gene polymorphisms with morphine pain relief
D. Campa et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Genetic variations and haplotype structures of the ABCB1 gene in a Japanese population:: An expanded haplotype block covering the distal promoter region, and associated ethnic differences
K. Sai et al.
ANNALS OF HUMAN GENETICS (2006)
Polymorphism of μ-opioid receptor gene (OPRM1:c.118A >G) does not protect against opioid-induced respiratory depression despite reduced analgesic response
RR Romberg et al.
ANESTHESIOLOGY (2005)
Are μ-opioid receptor polymorphisms important for clinical opioid therapy?
J Lötsch et al.
TRENDS IN MOLECULAR MEDICINE (2005)
Isoform selectivity and kinetics of morphine 3-and 6-glucuronidation by human UDP-glucuronosyltransferases: Evidence for atypical glucuronidation kinetics by UGT2B7
AN Stone et al.
DRUG METABOLISM AND DISPOSITION (2003)
Evidence for an active transport of morphine-6-β-D-glucuronide but not P-glycoprotein-mediated at the blood-brain barrier
F Bourasset et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Increased CNS uptake and enhanced antinociception of morphine-6-glucuronide in rats after inhibition of P-glycoprotein
J Lötsch et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Morphine glucuronide-to-morphine plasma ratios are unaffected by the UGT2B7 H268Y and UGT1A1*28 polymorphisms in cancer patients on chronic morphine therapy
M Holthe et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Blood-brain barrier transport and brain distribution of morphine-6-glucuronide in relation to the antinociceptive effect in rats-pharmacokinetic/pharmacodynamic modelling
MR Bouw et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Morphine-6β-glucuronide and morphine-3-glucuronide, opioid receptor agonists with different potencies
C Ulens et al.
BIOCHEMICAL PHARMACOLOGY (2001)
Modelling of the blood-brain barrier transport of morphine-3-glucuronide studied using microdialysis in the rat: involvement of probenecid-sensitive transport
RJ Xie et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Neuroexcitatory effects of morphine and hydromorphone: Evidence implicating the 3-glucuronide metabolites
MT Smith
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2000)
Antinociceptive effects of morphine-6-glucuronide in homozygous MDR1a P-glycoprotin knockout and in wildtype mice in the hotplate test
J Lötsch et al.
LIFE SCIENCES (2000)
Development of an in situ mouse brain perfusion model and its application to mdr1a P-glycoprotein-deficient mice
C Dagenais et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2000)
分享论文
